PP_1170x120_10-25-21

Rite Aid adds genetic testing to mix

Print Friendly, PDF & Email

CAMP HILL, Pa. — Rite Aid Corp. and Harmonyx, a leader in affordable and accessible genetic testing, have announced the availability of selected genetic tests in all Rite Aid pharmacies except those in New York state. Rite Aid is the first U.S. drug store chain to offer Harmonyx genetic testing.

The self-administered oral swab test will help patients determine the effectiveness of their prescription medication based on their genetic makeup. Currently, Rite Aid is offering genetic testing for three classes of medications including those used to manage cardiac conditions, cholesterol and attention deficit hyperactivity disorder. Rite Aid pharmacists are available to help patients and physicians determine if a particular test is medically appropriate.

“We are committed to offering our customers unique and innovative products, services and programs that meet their individual wellness needs, and personalized medication therapy through genetic testing is a perfect example of such a service,” said Rite Aid executive vice president of pharmacy Jocelyn Konrad. “By offering Harmonyx genetic testing to our customers, we’re helping to ensure that the medication they are taking is the most effective medication to help them treat and manage their condition while avoiding unnecessary and potentially harmful side ­effects.”

Customers can purchase the testing kit at any Rite Aid store (except those in New York). Once the customer’s cheek is swabbed, Rite Aid pharmacists return the sample to Harmonyx for processing. Harmonyx provides a state-licensed physician to review each patient test, and detailed results are returned to both the pharmacist and treating physician in as little as 24 hours once the laboratory receives the test. Pharmacists are available to discuss the results with the patient and their physician to find the best medication choice based on the patient’s genetic makeup and other relevant clinical factors.

“The more people who are aware of the availability and accessibility of these genetic tests, the greater the impact we can have on the health of our communities,” said Harmonyx president and chief executive officer Bob Bean. “With our tests now being at nearly 4,000 Rite Aid locations, we have an opportunity to make a true difference in the lives of people by making sure that the medication they are taking is the right therapy for them.”


ECRM-07-06-22


Comments are closed.